Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Allied Market Research | PRODUCT CODE: 1032587

Cover Image

PUBLISHER: Allied Market Research | PRODUCT CODE: 1032587

Implantable Insulin Pump Market by Type (Closed-Loop Insulin Pump and Open-Loop Insulin Pump), Disease (Type 1 Diabetes and Type 2 Diabetes), and End User (Hospitals and Home Care): Global Opportunity Analysis and Industry Forecast, 2021-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Excel (Data Pack)
USD 4125
PDF (Single User License + Covid impact)
USD 6168
PDF (5-user License)
USD 6929
PDF (Enterprise User License)
USD 10663

Add to Cart

The global implantable insulin pump market was valued at $2,674 million in 2020, and is projected to reach $6,443 million by 2030, registering a CAGR of 9.1% from 2021 to 2030.

Implantable insulin pump is a medical device that helps in delivering insulin into peritoneal cavity, and remains inside the human body all the time. Moreover, implanted insulin pumps aids in effective absorption of insulin. The implantable insulin pumps are projected to revolutionize the treatment of diabetes disease and also gives a constructive solution for accurately effective artificial pancreas. There are two types of implantable insulin pump such as closed-loop insulin pump and open-loop insulin pump. It is a next generation insulin that automatically responds to changing blood glucose levels. Moreover, it is a painless mode of delivering insulin compared to injectable insulin, minimizing the risk of skin irritation caused due to needles.

The growth of the implantable insulin pump market is driven by rise in prevalence of diabetes across the globe, increase in demand for implantable insulin pump, and accuracy in dosage delivery of insulin by implantable insulin pump. In addition, awareness about insulin treatment by healthcare professionals, technological advancements in implantable insulin pump, rise in patient emphasis on effective & early diabetes disease treatment, and increase in investment in R&D for insulin pumps are expected to boost the market growth during the forecast period. However, stringent government regulations expected to hamper the market growth during the forecast period. Conversely, high market growth potential in emerging markets is expected to offer lucrative opportunities during the forecast period.

The implantable insulin pump market is segmented on the basis of type, disease, end user, and region. On the basis of type, the market is categorized into closed-loop insulin pump and open-loop insulin pump. By disease, the market is divided into type 1 diabetes and type 2 diabetes. On the basis of end user, the market is categorized into hospitals and home care. The hospitals segment is further segmented into type 1 diabetes and type 2 diabetes. The home care segment is further segmented into type 1 diabetes and type 2 diabetes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Type

  • Closed-Loop Insulin Pump
  • Open-Loop Insulin Pump

By Disease

  • Type 1 Diabetes
  • Type 2 Diabetes

By End User

  • Hospitals
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Home Care
  • Type 1 Diabetes
  • Type 2 Diabetes

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Apex Medical
  • CVS Health (Aetna Inc)
  • Diabeloop
  • Diamesco Co., Ltd
  • F. Hoffmann La Roche Ltd
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic Plc
  • SOOIL Developments Co. Ltd
  • Tandem Diabetes Care
Product Code: A03079

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key Benefits for Stakeholders
  • 1.3.Key market segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five force analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in prevalence of diabetes worldwide
      • 3.5.1.2.Sedentary and unhealthy lifestyle pattern
      • 3.5.1.3.Increase in government expenditure on healthcare
    • 3.5.2.Restraint
      • 3.5.2.1.Stringent government regulations
    • 3.5.3.Opportunities
      • 3.5.3.1.High market growth potential in emerging markets
    • 3.5.4.Impact analysis
  • 3.6.Covid-19 Impact analysis on implantable insulin pump market

CHAPTER 4:IMPLANTABLE INSULIN PUMP MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Closed-loop insulin pump
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Open-loop insulin pump
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country

CHAPTER 5:IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Type 1 diabetes
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Type 2 diabetes
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country

CHAPTER 6:IMPLANTABLE INSULIN PUMP MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Hospitals
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
    • 6.2.3.Market size and forecast, by disease
  • 6.3.Home care
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country
    • 6.3.3.Market size and forecast, by disease

CHAPTER 7:IMPLANTABLE INSULIN PUMP MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.Market size and forecast, by country
      • 7.2.2.1.U.S.

U.S. implantable insulin pump market, by type

U.S. implantable insulin pump market, by disease

U.S. implantable insulin pump market, by end user

      • 7.2.2.2.Canada

Canada implantable insulin pump market, by type

Canada implantable insulin pump market, by disease

Canada implantable insulin pump market, by end user

      • 7.2.2.3.Mexico

Mexico implantable insulin pump market, by type

Mexico implantable insulin pump market, by disease

Mexico implantable insulin pump market, by end user

    • 7.2.3.North America market size and forecast, by type
    • 7.2.4.North America market size and forecast, by disease
    • 7.2.5.North America market size and forecast, by end user
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Market size and forecast, by country
      • 7.3.2.1.Germany

Germany implantable insulin pump market, by type

Germany implantable insulin pump market, by disease

Germany implantable insulin pump market, by end user

      • 7.3.2.2.France

France implantable insulin pump market, by type

France implantable insulin pump market, by disease

France implantable insulin pump market, by end user

      • 7.3.2.3.UK

UK implantable insulin pump market, by type

UK implantable insulin pump market, by disease

UK implantable insulin pump market, by end user

      • 7.3.2.4.Italy

Italy implantable insulin pump market, by type

Italy implantable insulin pump market, by disease

Italy implantable insulin pump market, by end user

      • 7.3.2.5.Spain

Spain implantable insulin pump market, by type

Spain implantable insulin pump market, by disease

Spain implantable insulin pump market, by end user

      • 7.3.2.6.Rest of Europe

Rest of Europe implantable insulin pump market, by type

Rest of Europe implantable insulin pump market, by disease

Rest of Europe implantable insulin pump market, by end user

    • 7.3.3.Europe market size and forecast, by type
    • 7.3.4.Europe market size and forecast, by disease
    • 7.3.5.Europe market size and forecast, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Market size and forecast, by country
      • 7.4.2.1.Japan

Japan implantable insulin pump market, by type

Japan implantable insulin pump market, by disease

Japan implantable insulin pump market, by end user

      • 7.4.2.2.China

China implantable insulin pump market, by type

China implantable insulin pump market, by disease

China implantable insulin pump market, by end user

      • 7.4.2.3.Australia

Australia implantable insulin pump market, by type

Australia implantable insulin pump market, by disease

Australia implantable insulin pump market, by end user

      • 7.4.2.4.India

India implantable insulin pump market, by type

India implantable insulin pump market, by disease

India implantable insulin pump market, by end user

      • 7.4.2.5.South Korea

South Korea implantable insulin pump market, by type

South Korea implantable insulin pump market, by disease

South Korea implantable insulin pump market, by end user

      • 7.4.2.6.Rest of Asia-Pacific

Rest of Asia-Pacific implantable insulin pump market, by type

Rest of Asia-Pacific implantable insulin pump market, by disease

Rest of Asia-Pacific implantable insulin pump market, by end user

    • 7.4.3.Asia-Pacific market size and forecast, by type
    • 7.4.4.Asia-Pacific market size and forecast, by disease
    • 7.4.5.Asia-Pacific market size and forecast, by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.Market size and forecast, by country
      • 7.5.2.1.Brazil

Brazil implantable insulin pump market, by type

Brazil implantable insulin pump market, by disease

Brazil implantable insulin pump market, by end user

      • 7.5.2.2.Saudi Arabia

Saudi Arabia implantable insulin pump market, by type

Saudi Arabia implantable insulin pump market, by disease

Saudi Arabia implantable insulin pump market, by end user

      • 7.5.2.3.South Africa

South Africa implantable insulin pump market, by type

South Africa implantable insulin pump market, by disease

South Africa implantable insulin pump market, by end user

      • 7.5.2.4.Rest of LAMEA

Rest of LAMEA implantable insulin pump market, by type

Rest of LAMEA implantable insulin pump market, by disease

Rest of LAMEA implantable insulin pump market, by end user

    • 7.5.3.LAMEA market size and forecast, by type
    • 7.5.4.LAMEA market size and forecast, by disease
    • 7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

  • 8.1.Apex Medical
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
  • 8.2.CVS Health (Aetna Inc.)
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product portfolio
    • 8.2.5.Business performance
  • 8.3.Diabeloop SACA
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Key strategic moves and developments
  • 8.4.DIAMESCO CO., LTD.
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
  • 8.5.F. Hoffmann La Roche Ltd.
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
    • 8.5.5.Business performance
    • 8.5.6.Key strategic moves and developments
  • 8.6.Insulet Corporation
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
    • 8.6.5.Business performance
    • 8.6.6.Key strategic moves and developments
  • 8.7.Johnson & Johnson
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Product portfolio
    • 8.7.5.Business performance
  • 8.8.Medtronic PLC.
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
    • 8.8.5.Business performance
    • 8.8.6.Key strategic moves and developments
  • 8.9.Sooil Developments Co. Ltd.
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Key strategic moves and developments
  • 8.10.Tandem Diabetes Care Inc.
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio
    • 8.10.5.Business performance
    • 8.10.6.Key strategic moves and developments
Product Code: A03079

LIST OF TABLES

  • TABLE 01.IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 02.CLOSED-LOOP INSULIN PUMP MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 03.CHIMERIC IMPLANTABLE INSULIN PUMP MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 04.IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 05.IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 1 DIABETES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 06.IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 2 DIABETES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 07.IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 08.IMPLANTABLE INSULIN PUMP MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 09.IMPLANTABLE INSULIN PUMP MARKET FOR HOSPITALS, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 10.IMPLANTABLE INSULIN PUMP MARKET FOR HOME CARE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.IMPLANTABLE INSULIN PUMP MARKET FOR HOME CARE, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 12.IMPLANTABLE INSULIN PUMP MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 13.NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 14.U.S. IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 15.U.S. IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 16.U.S. IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 17.CANADA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 18.CANADA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 19.CANADA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 20.MEXICO IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 21.MEXICO IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 22.MEXICO IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 23.NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 24.NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 25.NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 26.EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 27.GERMANY IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 28.GERMANY IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 29.GERMANY IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 30.FRANCE IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 31.FRANCE IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 32.FRANCE IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 33.UK IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 34.UK IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 35.UK IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 36.ITALY IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 37.ITALY IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 38.ITALY IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 39.SPAIN IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 40.SPAIN IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 41.SPAIN IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 42.REST OF EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 43.REST OF EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 44.REST OF EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 45.EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 46.EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 47.EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 48.ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 49.JAPAN IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 50.JAPAN IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 51.JAPAN IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 52.CHINA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 53.CHINA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 54.CHINA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 55.AUSTRALIA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 56.AUSTRALIA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 57.AUSTRALIA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 58.INDIA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 59.INDIA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 60.INDIA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 61.SOUTH KOREA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 62.SOUTH KOREA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 63.SOUTH KOREA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 64.REST OF ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 65.REST OF ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 66.REST OF ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 67.ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 68.ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 69.ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 70.LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 71.BRAZIL IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 72.BRAZIL IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 73.BRAZIL IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 74.SAUDI ARABIA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 75.SAUDI ARABIA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 76.SAUDI ARABIA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 77.SOUTH AFRICA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 78.SOUTH AFRICA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 79.SOUTH AFRICA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 80.REST OF LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 81.REST OF LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 82.REST OF LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 83.LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 84.LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
  • TABLE 85.LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 86.APEX MEDICAL: COMPANY SNAPSHOT
  • TABLE 87.APEX MEDICAL: OPERATING SEGMENTS
  • TABLE 88.APEX MEDICAL: PRODUCT PORTFOLIO
  • TABLE 89.CVS HEALTH (ATENA INC).: COMPANY SNAPSHOT
  • TABLE 90.CVS HEALTH (AETNA INC).: OPERATING SEGMENTS
  • TABLE 91.CVS HEALTH (AETNA INC.): PRODUCT PORTFOLIO
  • TABLE 92.DIABELOOP SACA: COMPANY SNAPSHOT
  • TABLE 93.DIABELOOP SACA: OPERATING SEGMENTS
  • TABLE 94.DIABELOOP SACA: PRODUCT PORTFOLIO
  • TABLE 95.DIABELOOP SACA.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96.DIAMESCO: COMPANY SNAPSHOT
  • TABLE 97.DIAMESCO: OPERATING SEGMENTS
  • TABLE 98.DIAMESCO: PRODUCT PORTFOLIO
  • TABLE 99.F. HOFFMANN LA ROCHE LTD: COMPANY SNAPSHOT
  • TABLE 100.F. HOFFMANN LA ROCHE LTD: OPERATING SEGMENTS
  • TABLE 101.F. HOFFMANN LA ROCHE LTD: PRODUCT PORTFOLIO
  • TABLE 102.F. HOFFMANN LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103.INSULET CORPORATION: COMPANY SNAPSHOT
  • TABLE 104.INSULET CORPORATION: OPERATING SEGMENTS
  • TABLE 105.INSULET CORPORATION: PRODUCT PORTFOLIO
  • TABLE 106.INSULET CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107.JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 108.JOHNSON & JOHNSON: OPERATING SEGMENTS
  • TABLE 109.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 110.MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 111.MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 112.MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 113.MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114.SOOIL DEVELOPMENTS CO. LTD.: COMPANY SNAPSHOT
  • TABLE 115.SOOIL DEVELOPMENTS CO. LTD.: OPERATING SEGMENTS
  • TABLE 116.SOOIL DEVELOPMENTS CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 117.SOOIL DEVELOPMENTS CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118.TANDEM DIABETES CARE INC.: COMPANY SNAPSHOT
  • TABLE 119.TANDEM DIABETES CARE INC.: OPERATING SEGMENTS
  • TABLE 120.TANDEM DIABETES CARE INC: PRODUCT PORTFOLIO
  • TABLE 121.TANDEM DIABETES CARE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 01.IMPLANTABLE INSULIN PUMP MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 01.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 02.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 03.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 04.LOW THREAT OF NEW ENTRANTS
  • FIGURE 05.HIGH INTENSITY OF RIVALRY
  • FIGURE 06.TOP PLAYER POSITIONING, 2020
  • FIGURE 07.IMPACT ANALYSIS
  • FIGURE 08.COMPARATIVE ANALYSIS OF CLOSED-LOOP INSULIN PUMP MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 09.COMPARATIVE ANALYSIS OF CHIMERIC IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 10.COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 11.COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 12.COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 13.COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR HOME CARE, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 14.CVS HEALTH (ATENA INC).: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 15.F. HOFFMANN LA ROCHE LTD: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 16.INSULET CORPORATION: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 17.INSULET CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 18.INSULET CORPORATION: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 19.JOHNSON & JOHNSON: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 20.JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 21.JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 22.MEDTRONIC PLC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 23.MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 24.MEDTRONIC PLC: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 25.TANDEM DIABETES CARE INC.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 26.TANDEM DIABETES CARE INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!